News XORTX Announces Participation at Upcoming Investor Conferences Continue Reading Previous Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial ResistanceNext XORTX Announces Participation at Upcoming Investor Conferences Related Stories News Digital Lifestyle Expert Mario Armstrong and News Media Group, Inc. Showcase the Ultimate “Cool for School” Tech and Learning Essentials on a Nationwide Satellite Media Tour News Enablence Engages Leading Investor Relations Firm The Blueshirt Group News Bitzero Announces Closing of US$25 Million Private Placement News Boardwalktech Reports Fourth Quarter and Annual Fiscal 2026 Financial Results News Enablence Technologies Engages Canaccord Genuity as Market Maker News Parvis Reports Fiscal Year 2026
